Human botulinum neurotoxin A/B immune globulin

DB14115

biotech approved

Deskripsi

Infant botulism is a rare infectious disease occurring in infants in which Clostridium botulinum colonize the large intestine and being to produce botulinum neurotoxin directly in the gut. As these neurotoxins interfere with cholinergic nervous transmission, patients initially present with evident of loss of muscle tone (e.g. constipation, ptosis, feeding difficulties) which may progress to more serious symptoms such as respiratory arrest and flaccid paralysis.L39819,L39824

BabyBIG (human-derived botulism immunoglobulin) was approved for use by the FDA in 2003L39814 and has since been used to treat more than 2100 cases of infant botulism.L39834 It is produced and distributed by the Calfornia Department of Public Health's Infant Botulism Treatment and Prevention ProgramL39829 and comprises IgG antibodies derived from pooled adult plasma from persons immunized with recombinant botulinum vaccine who have high titers of neutralizing antibodies against botulinum toxin.L39814

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The half-life of human-derived botulism immunoglobulin is approximately 28 days in infants, which is similar to other immunoglobulin preparations.[L39814]
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Contoh Produk & Brand

Produk: 1 • International brands: 0
Produk
  • BabyBIG
    Injection, powder, lyophilized, for solution • 50 mg/1mL • Intravenous • US • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul